North America Cell Line Development Market to Grow at a CAGR of 13.6% to reach US$ 3,849.54 million from 2020 to 2027

North America Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line), Product (Equipment, and Media & Reagent), Application (Drug Discovery, Bioproduction, and Tissue Engineering), and Country

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027
  • Status : Published
  • Report Code : TIPRE00020095
  • Category : Life Sciences
  • No. of Pages : 157
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 14, 2021
North America Cell Line Development Market to Grow at a CAGR of 13.6% to reach US$ 3,849.54 million from 2020 to 2027
Report Date: April 14, 2021   |   Report Code: TIPRE00020095 Email: sales@theinsightpartners.com

2019 Market Size

US$ 1,401.23 Mn

Base year value

2027 Forecast

US$ 3,849.54 Mn

Projected by 2027

CAGR 2020-2027

13.6 %

Growth rate

Addressable Market

US$ 20,757.63 Mn

(2020-2027)

The North America cell line development market is expected to reach US$ 3,849.54million in 2027 from US$ 1,401.23 million in 2019. The market is estimated to grow with a CAGR of 13.6% from 2020-2027.  

The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment. The scope of the cell line development market includes type, product, application, and region.

US Cell line development Market Revenue and Forecasts to 2027 (US$ MN)

US Cell line development Market Revenue and Forecasts to 2027 (US$ MN)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA CELL LINE DEVELOPMENT MARKET SEGMENTATION

By Type

  • Primary Cell Line
  • Hybridomas
  • Continuous Cell Lines
  • Recombinant Cell Line

By Product

  • Equipment
  • Media & Reagent

By Application

  • Drug Discovery
  • Bioproduction
  • Tissue Engineering

By Country

  • North America
  • US
  • Canada
  • Mexico

Company Profiles

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • SELEXIS
  • BioFactura, Inc.
  • WuXi AppTec
  • LakePharma, Inc.
  • General Electric
  • Lonza
  • Corning Incorporated

North America Cell Line Development Report Scope

Report Attribute Details
Market size in 2019 US$ 1,401.23 Million
Market Size by 2027 US$ 3,849.54 Million
CAGR (2020 - 2027) 13.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • Primary Cell Line
  • Hybridomas
  • Continuous Cell Lines
  • Recombinant Cell Line
By Product
  • Equipment
  • Media & Reagent
By Application
  • Drug Discovery
  • Bioproduction
  • Tissue Engineering
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • SELEXIS
  • BioFactura, Inc.
  • WuXi AppTec
  • LakePharma, Inc.
  • General Electric
  • Lonza
  • Corning Incorporated
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA